| Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo … C Lerman, RA Schnoll, LW Hawk, P Cinciripini, TP George, EP Wileyto, ... The lancet Respiratory medicine 3 (2), 131-138, 2015 | 281 | 2015 |
| Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study RA Schnoll, F Patterson, EP Wileyto, RF Tyndale, N Benowitz, C Lerman Pharmacology Biochemistry and Behavior 92 (1), 6-11, 2009 | 239 | 2009 |
| A structural model of the relationships among stage of disease, age, coping, and psychological adjustment in women with breast cancer RA Schnoll, LL Harlow, LL Stolbach, U Brandt Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 1998 | 211 | 1998 |
| Toward personalized therapy for smoking cessation: a randomized placebo‐controlled trial of bupropion F Patterson, RA Schnoll, EP Wileyto, A Pinto, LH Epstein, PG Shields, ... Clinical Pharmacology & Therapeutics 84 (3), 320-325, 2008 | 200 | 2008 |
| Correlates of tobacco use among smokers and recent quitters diagnosed with cancer RA Schnoll, M Malstrom, C James, RL Rothman, SM Miller, JA Ridge, ... Patient education and counseling 46 (2), 137-145, 2002 | 194 | 2002 |
| Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial RA Schnoll, F Patterson, EP Wileyto, DF Heitjan, AE Shields, DA Asch, ... Annals of internal medicine 152 (3), 144-151, 2010 | 159 | 2010 |
| Increased self-efficacy to quit and perceived control over withdrawal symptoms predict smoking cessation following nicotine dependence treatment RA Schnoll, E Martinez, KL Tatum, M Glass, A Bernath, D Ferris, ... Addictive behaviors 36 (1-2), 144-147, 2011 | 154 | 2011 |
| Long-term nicotine replacement therapy: a randomized clinical trial RA Schnoll, PM Goelz, A Veluz-Wilkins, S Blazekovic, L Powers, ... JAMA internal medicine 175 (4), 504-511, 2015 | 145 | 2015 |
| Brief physician-initiated quit-smoking strategies for clinical oncology settings: a trial coordinated by the Eastern Cooperative Oncology Group RA Schnoll, B Zhang, M Rue, JE Krook, WT Spears, AC Marcus, ... Journal of Clinical Oncology 21 (2), 355-365, 2003 | 145 | 2003 |
| Current and emerging pharmacotherapies for treating tobacco dependence RA Schnoll, C Lerman Expert opinion on emerging drugs 11 (3), 429-444, 2006 | 133 | 2006 |
| Smoking cessation treatment by primary care physicians: an update and call for training RA Schnoll, M Rukstalis, EP Wileyto, AE Shields American journal of preventive medicine 31 (3), 233-239, 2006 | 133 | 2006 |
| Correlates of adjustment among cancer survivors RA Schnoll, JC Knowles, L Harlow Journal of psychosocial oncology 20 (1), 37-59, 2002 | 133 | 2002 |
| Measuring cancer patients' psychological distress and well-being: a factor analytic assessment of the Mental Health Inventory. S Manne, R Schnoll Psychological Assessment 13 (1), 99, 2001 | 128 | 2001 |
| Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers MJ Chenoweth, M Novalen, LW Hawk Jr, RA Schnoll, TP George, ... Cancer Epidemiology, Biomarkers & Prevention 23 (9), 1773-1782, 2014 | 124 | 2014 |
| Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for … RA Schnoll, RL Rothman, H Newman, C Lerman, SM Miller, B Movsas, ... Psycho‐Oncology: Journal of the Psychological, Social and Behavioral …, 2004 | 118 | 2004 |
| Longitudinal predictors of continued tobacco use among patients diagnosed with cancer RA Schnoll, J Calvin, M Malstrom, RL Rothman, H Wang, J Babb, ... Annals of Behavioral Medicine 25 (3), 214-221, 2003 | 118 | 2003 |
| Genetic variation in nicotine metabolism predicts the efficacy of extended‐duration transdermal nicotine therapy C Lerman, C Jepson, EP Wileyto, F Patterson, R Schnoll, M Mroziewicz, ... Clinical Pharmacology & Therapeutics 87 (5), 553-557, 2010 | 117 | 2010 |
| Treating tobacco dependence in women RA Schnoll, F Patterson, C Lerman Journal of Women's Health 16 (8), 1211-1218, 2007 | 108 | 2007 |
| Genetics and smoking cessation: improving outcomes in smokers at risk CE Lerman, RA Schnoll, MR Munafò American journal of preventive medicine 33 (6), S398-S405, 2007 | 102 | 2007 |
| Clinical strategies to enhance the efficacy of nicotine replacement therapy for smoking cessation: a review of the literature MJ Carpenter, BF Jardin, JL Burris, AR Mathew, RA Schnoll, NA Rigotti, ... Drugs 73, 407-426, 2013 | 99 | 2013 |
